A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective T(H)1-Type Humoral and Cellular Immunity In Rodent Models

BACKGROUND: Illness associated with Respiratory Syncytial Virus (RSV) remains an unmet medical need in both full-term infants and older adults. The fusion glycoprotein (F) of RSV, which plays a key role in RSV infection and is a target of neutralizing antibodies, is an attractive vaccine target for...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Stacie L., Aslam, Shahin, Stillman, Elizabeth, MacPhail, Mia, Nelson, Christine, Ro, Bodrey, Sweetwood, Rosemary, Lei, Yuk Man, Woo, Jennifer C., Tang, Roderick S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368639/
https://www.ncbi.nlm.nih.gov/pubmed/25793508
http://dx.doi.org/10.1371/journal.pone.0119509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368639/
https://www.ncbi.nlm.nih.gov/pubmed/25793508
http://dx.doi.org/10.1371/journal.pone.0119509

Ejemplares similares